Epstein-barr virus latent membrane protein-2a induces ITAM/syk- and akt-dependent epithelial migration through αV-integrin membrane translocation

Journal of Virology

Volumn 86, Issue 19, 2012, Pages 10308-10320

  Fotheringham, Julie A ^a   Coalson, Nicole E ^a   Raab Traub, Nancy ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD51 ANTIGEN; CHEMOATTRACTANT; COLLAGEN; FIBRONECTIN; FOCAL ADHESION KINASE; GLYCOGEN SYNTHASE KINASE 3BETA; LATENT MEMBRANE PROTEIN 2; LATENT MEMBRANE PROTEIN 2A; PROTEIN KINASE B; PROTEIN KINASE SYK; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ARTICLE; CELL ASSAY; CELL IMMORTALIZATION; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; KERATINOCYTE; MEMBRANE TRANSPORT; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; PROTEIN TARGETING; SIGNAL TRANSDUCTION;

AMINO ACID MOTIFS; CELL LINE; CELL MOVEMENT; CHEMOTACTIC FACTORS; EPITHELIAL CELLS; EPITHELIUM; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HERPESVIRUS 4, HUMAN; HUMANS; INTEGRIN ALPHAV; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KERATINOCYTES; MICROSCOPY, FLUORESCENCE; PROTEIN STRUCTURE, TERTIARY; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; VIRAL MATRIX PROTEINS; WOUND HEALING;

HERPESVIRIDAE; HUMAN HERPESVIRUS 4;

EID: 84869032266     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00853-12     Document Type: Article

References (36)

1. Allen MD, Young LS, Dawson CW. 2005. The Epstein-Barr virusencoded LMP2A and LMP2B proteins promote epithelial cell spreading and motility. J. Virol. 79:1789-1802.
2. Bacac M, Stamenkovic I. 2008. Metastatic cancer cell. Annu. Rev. Pathol.3:221-247.
3. Bianchi M, et al. 2005. Regulation of FAK Ser-722 phosphorylation and kinase activity by GSK3 and PP1 during cell spreading and migration. Biochem. J. 391:359-370.
4. Brooks L, Yao QY, Rickinson AB, Young LS. 1992. Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts. J. Virol. 66:2689-2697.
5. Busson P, et al. 1992. Consistent transcription of the Epstein-Barr virus LMP2 gene in nasopharyngeal carcinoma. J. Virol. 66:3257-3262.
6. Desgrosellier JS, Cheresh DA. 2010. Integrins in cancer: biological implications and therapeutic opportunities. Nat. Rev. Cancer 10:9-22.
7. Fotheringham JA, Mazzucca S, Raab-Traub N. 2010. Epstein-Barr virus latent membrane protein-2A-induced DeltaNp63alpha expression is associated with impaired epithelial-cell differentiation. Oncogene 29:4287-
8. Fruehling S, Longnecker R. 1997. The immunoreceptor tyrosine-based activation motif of Epstein-Barr virus LMP2A is essential for blocking BCR-mediated signal transduction. Virology 235:241-251.
9. Fruehling S, Swart R, Dolwick KM, Kremmer E, Longnecker R. 1998. Tyrosine 112 of latent membrane protein 2A is essential for protein tyrosine kinase loading and regulation of Epstein-Barr virus latency. J. Virol.
10. Fukuda M, Longnecker R. 2007. Epstein-Barr virus latent membrane protein 2A mediates transformation through constitutive activation of the Ras/PI3-K/Akt Pathway. J. Virol. 81:9299-9306.
11. Gupta SK, Vlahakis NE. 2009. Integrin alpha9beta1 mediates enhanced cell migration through nitric oxide synthase activity regulated by Src tyrosine kinase. J. Cell Sci. 122:2043-2054.
12. Ikeda M, Ikeda A, Longan LC, Longnecker R. 2000. The Epstein-Barr virus latent membrane protein 2A PY motif recruits WW domaincontaining ubiquitin-protein ligases. Virology 268:178-191.
13. Kobayashi T, et al. 2006. Glycogen synthase kinase 3 and h-prune regulate cell migration by modulating focal adhesions. Mol. Cell. Biol. 26:898-911.
14. Lan YY, et al. 2012. Epstein-Barr virus latent membrane protein 2A promotes invasion of nasopharyngeal carcinoma cells through ERK/Fra- 1-mediated induction of matrix metalloproteinase 9. J. Virol. 86:6656-6667.
15. Lu J, et al. 2006. Syk tyrosine kinase mediates Epstein-Barr virus latent membrane protein 2A-induced cell migration in epithelial cells. J. Biol. Chem. 281:8806-8814.
16. Margadant C, Monsuur HN, Norman JC, Sonnenberg A. 2011. Mechanisms of integrin activation and trafficking. Curr. Opin. Cell Biol. 23: 607-614.
17. Miller CL, et al. 1995. Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases. Immunity 2:155-166.
18. Montgomery AM, Reisfeld RA, Cheresh DA. 1994. Integrin alpha v beta 3 rescues melanoma cells from apoptosis in three-dimensional dermal collagen. Proc. Natl. Acad. Sci. U. S. A. 91:8856-8860.
19. Nemoto T, et al. 2008. Regulation of Akt mRNA and protein levels by glycogen synthase kinase-3beta in adrenal chromaffin cells: effects of LiCl and SB216763. Eur. J. Pharmacol. 586:82-89.
20. Pegtel DM, et al. 2005. Epstein-Barr-virus-encoded LMP2A induces primary epithelial cell migration and invasion: possible role in nasopharyngeal carcinoma metastasis. J. Virol. 79:15430-15442.
21. Raab-Traub N. 1992. Epstein-Barr virus and nasopharyngeal carcinoma. Semin. Cancer Biol. 3:297-307.
22. Raab-Traub N. 2002. Epstein-Barr virus in the pathogenesis of NPC. Semin. Cancer Biol. 12:431-441.
23. Raab-Traub N. 1992. Epstein-Barr virus infection in nasopharyngeal carcinoma. Infect. Agents Dis. 1:173-184.
24. Rickinson AB, Kieff E. 2001. Epstein-Barr virus, 4th ed. Lippincott/ Williams & Wilkins, Philadelphia, PA.
25. Salah Z, Melino G, Aqeilan RI. 2011. Negative regulation of the Hippo pathway by E3 ubiquitin ligase ITCH is sufficient to promote tumorigenicity. Cancer Res. 71:2010-2020.
26. Scholle F, Bendt KM, Raab-Traub N. 2000. Epstein-Barr virus LMP2A transforms epithelial cells, inhibits cell differentiation, and activates Akt. J. Virol. 74:10681-10689.
27. Seo MD, Park SJ, Kim HJ, Lee BJ. 2007. Identification of the WW domain-interaction sites in the unstructured N-terminal domain of EBV LMP 2A. FEBS Lett. 581:65-70.
28. Shair KH, Schnegg CI, Raab-Traub N. 2008. EBV latent membrane protein 1 effects on plakoglobin, cell growth, and migration. Cancer Res. 68:6997-7005.
29. Shair KH, Schnegg CI, Raab-Traub N. 2009. Epstein-Barr virus latent membrane protein-1 effects on junctional plakoglobin and induction of a cadherin switch. Cancer Res. 69:5734-5742.
30. Swart R, Ruf IK, Sample J, Longnecker R. 2000. Latent membrane protein 2A-mediated effects on the phosphatidylinositol 3-kinase/Akt pathway. J. Virol. 74:10838-10845.
31. Vasudevan KM, Garraway LA. 2010. AKT signaling in physiology and disease. Curr. Top. Microbiol. Immunol. 347:105-133.
32. Wang C, et al. 2012. The Nedd4-like ubiquitin E3 ligases target angiomotin/ P130 to ubiquitin-dependent degradation. Biochem. J. 444:279-289.
33. Wilder RL. 2002. Integrin alpha V beta 3 as a target for treatment of rheumatoid arthritis and related rheumatic diseases. Ann. Rheum. Dis. 61(Suppl 2):ii96-ii99.
34. Yadav V, Denning MF. 2011. Fyn is induced by Ras/PI3K/Akt signaling and is required for enhanced invasion/migration. Mol. Carcinog. 50:346-352.
35. Young LS, Rowe M. 1992. Epstein-Barr virus, lymphomas and Hodgkin's disease. Semin. Cancer Biol. 3:273-284.
36. Zhao X, Guan JL. 2011. Focal adhesion kinase and its signaling pathways in cell migration and angiogenesis. Adv. Drug Deliv. Rev. 63:610-615.